Search results for "Disease management"

showing 10 items of 168 documents

Economic costs associated with acute attacks and long-term management of hereditary angioedema.

2010

Background Hereditary angioedema (HAE) is a rare autosomal dominant disorder characterized by recurrent acute attacks of swelling of the larynx, abdomen, and periphery. Objective To assess the economic burden associated with acute attacks and long-term management of HAE. Methods Burden was assessed via a Web-based survey of HAE patients (≥18 years old) that solicited information on attack characterization, short-term treatment, long-term disease management, impact on work, and patient costs. A standardized instrument, the Work Productivity and Activity Impairment questionnaire, was included to assess impact on work productivity. Standard medical costs and US average wage costs were assigned…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyEmergency Medical Servicesmedia_common.quotation_subjectImmunologyWageDrug CostsIndirect costsCost of IllnessEconomic costSurveys and QuestionnairesLong term managementmedicineImmunology and AllergyHumansDisease management (health)Hospital CostsProductivityhealth care economics and organizationsmedia_commonbusiness.industryAngioedemas HereditaryEmergency departmentHealth Care Costsmedicine.diseaseHospitalizationHealth Care SurveysEmergency medicineHereditary angioedemaAcute DiseasePhysical therapyFemalebusinessAnnals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology
researchProduct

A Bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnoea: a multicentre randomised controlled trial

2015

Background Compliance with continuous positive airway pressure (CPAP) therapy is essential in patients with obstructive sleep apnoea (OSA), but adequate control is not always possible. This is clinically important because CPAP can reverse the morbidity and mortality associated with OSA. Telemedicine, with support provided via a web platform and video conferences, could represent a cost-effective alternative to standard care management. Aim To assess the telemedicine impact on treatment compliance, cost-effectiveness and improvement in quality of life (QoL) when compared with traditional face-to-face follow-up. Methods A randomised controlled trial was performed to compare a telemedicine-bas…

Pulmonary and Respiratory MedicineMaleTelemedicinemedicine.medical_specialtyEpidemiologymedicine.medical_treatmentCost-Benefit Analysislaw.inventionIndirect costsClinical trialsQuality of lifeRandomized controlled triallawmedicineHumansContinuous positive airway pressureProspective StudiesDisease management (health)EpidemiologiaTelecommunication in medicineSleep apnea syndromesPrimary health careSleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industryDisease ManagementBayes TheoremCost-effectiveness analysisSíndromes d'apnea del sonMiddle AgedTelemedicinenervous system diseasesrespiratory tract diseasesClinical trialAtenció primàriaPhysical therapyQuality of LifePatient ComplianceFemalebusinessSleepFollow-Up StudiesTelecomunicació en medicinaAssaigs clínics
researchProduct

An Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly.

2016

Asthma in the elderly (>65 yr old) is common and associated with higher morbidity and mortality than asthma in younger patients. The poor outcomes in this group are due, in part, to underdiagnosis and undertreatment. There are a variety of factors related to aging itself that affect the presentation of asthma in the elderly and influence diagnosis and management. Structural changes in the aging lung superimposed on structural changes due to asthma itself can worsen the disease and physiologic function. Changes in the aging immune system influence the cellular composition and function in asthmatic airways. These processes and differences from younger individuals with asthma are not well u…

Pulmonary and Respiratory MedicinePediatricsmedicine.medical_specialtyAgingImmunosenescenceaging; immunosenescence; lung function; phenotype; reactive airways diseaseDiseaseComorbiditySettore MED/10 - Malattie Dell'Apparato RespiratorioAffect (psychology)Diagnosis Differential03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineimmune system diseasesreactive airways diseasemedicineHumans030212 general & internal medicineDisease management (health)LungSocieties MedicalAsthmaAgedAmerican Thoracic Society DocumentsLungbusiness.industryDisease Managementlung functionImmunosenescencemedicine.diseaseComorbidityAsthmaUnited Statesrespiratory tract diseasesmedicine.anatomical_structurePhenotype030228 respiratory systemPhysical therapyAge of onsetbusinessBiomarkersAnnals of the American Thoracic Society
researchProduct

Mild obstructive sleep apnoea: clinical relevance and approaches to management

2015

Summary Obstructive sleep apnoea is highly prevalent in the general population worldwide, especially in its mild form. Clinical manifestations correlate poorly with disease severity measured by the apnoea–hypopnoea index (AHI), which complicates diagnosis. Full polysomnography might be more appropriate to assess suspected mild cases because limited ambulatory diagnostic systems are least accurate in mild disease. Treatment options in mild obstructive sleep apnoea include continuous positive airway pressure (CPAP) and oral appliance therapy, in addition to positional therapy and weight reduction when appropriate. The superior efficacy of CPAP in reducing AHI is offset by greater tolerance of…

Pulmonary and Respiratory MedicineRespiratory Therapymedicine.medical_specialtymedicine.medical_treatmentOral appliancePopulationPolysomnographySettore MED/10 - Malattie Dell'Apparato RespiratorioPatient Positioning03 medical and health sciences0302 clinical medicinestomatognathic systemmedicineHumansClinical significanceContinuous positive airway pressureDisease management (health)Intensive care medicineeducationSleep Apnea Obstructiveeducation.field_of_studyContinuous Positive Airway Pressuremedicine.diagnostic_testbusiness.industryDisease ManagementSleep apneamedicine.diseasenervous system diseasesrespiratory tract diseases030228 respiratory systemAmbulatoryPhysical therapybusiness030217 neurology & neurosurgery
researchProduct

Impact of a Supervised Training Course on Spirometry Competency for Primary Care Pediatricians

2020

Objective: Spirometry is the most commonly performed lung function test, and performance, adherence to acceptability and repeatability criteria, and accurate interpretation of results help optimize the test's usefulness. This study aimed to measure the effects of spirometry training courses supported by the Italian Pediatric Respiratory Society (IPRS) on primary care pediatricians' (PCP) knowledge of spirometry test quality, ability to interpret results, and overall degree of satisfaction with the course.Methods: Of the six face-to-face courses, four lasted two days and two lasted one day: mean duration of theoretical lessons was five and four hours respectively; and practical sessions last…

Pulmonary and Respiratory MedicineSpirometryAdultMalemedicine.medical_specialtyHealth Knowledge Attitudes PracticeknowledgePilot ProjectsPrimary carePulmonary function testing03 medical and health sciencesprimary care0302 clinical medicinechildren030225 pediatricsmedicineImmunology and AllergyHumanspediatriciansDisease management (health)Supervised trainingAsthmamedicine.diagnostic_testbusiness.industryspirometry training.pediatricianMiddle Agedmedicine.diseasepractice030228 respiratory systemdisease managementSpirometryPediatrics Perinatology and Child HealthPhysical therapyEducation Medical ContinuingFemaleClinical Competencebusinessspirometry training
researchProduct

Severe eosinophilic asthma: a roadmap to consensus

2017

Asthma is widely accepted as a complex heterogeneous condition with diverse pathophysiological mechanisms, clinical presentations, comorbidities, physiological characteristics, pathology and outcomes that is typically best managed by a multidisciplinary team [1–4]. Severe asthma is recognised as a major unmet need with a high personal and social impact, as well as a high burden on healthcare resources [4]. As a consequence of advances in the development of precision medicines for patients with severe asthma, the need to identify asthma subtypes by phenotype based on clinical, functional or inflammatory parameters is becoming a mandatory part of management [4–6]. Severe eosinophilic asthma (…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyConsensusEosinophilic asthmamacromolecular substancesSeverity of Illness IndexBiological Factors03 medical and health sciences0302 clinical medicineimmune system diseasesEosinophilicmedicineHumans030212 general & internal medicinePulmonary EosinophiliaIntensive care medicineSocieties MedicalTask forcebusiness.industryDisease ManagementAsthmarespiratory tract diseasesEurope030228 respiratory systemImmunologybusinessEuropean Respiratory Journal
researchProduct

Years of life that could be saved from prevention of hepatocellular carcinoma

2016

Summary Background Hepatocellular carcinoma (HCC) causes premature death and loss of life expectancy worldwide. Its primary and secondary prevention can result in a significant number of years of life saved. Aim To assess how many years of life are lost after HCC diagnosis. Methods Data from 5346 patients with first HCC diagnosis were used to estimate lifespan and number of years of life lost after tumour onset, using a semi-parametric extrapolation having as reference an age-, sex- and year-of-onset-matched population derived from national life tables. Results Between 1986 and 2014, HCC lead to an average of 11.5 years-of-life lost for each patient. The youngest age-quartile group (18–61 y…

RegistrieMalePediatricsDatabases FactualHepatocellular carcinoma0302 clinical medicineprevention80 and overSecondary PreventionPharmacology (medical)Prospective StudiesRegistriesYoung adultProspective cohort studySecondary preventionAged 80 and overeducation.field_of_studyLiver NeoplasmsGastroenterologyDisease ManagementMiddle AgedPrimary PreventiondiagnosiItalyLiver Neoplasm030220 oncology & carcinogenesisHepatocellular carcinoma030211 gastroenterology & hepatologyFemaleHumanAdultmedicine.medical_specialtyCarcinoma HepatocellularAdolescentPopulationlife expentancyMilan criteria03 medical and health sciencesDatabasesYoung AdultLife ExpectancymedicineHumansAdolescent; Adult; Aged; Aged 80 and over; Carcinoma Hepatocellular; Databases Factual; Disease Management; Female; Humans; Italy; Life Expectancy; Liver Neoplasms; Male; Middle Aged; Primary Prevention; Prospective Studies; Registries; Secondary Prevention; Young Adult; Pharmacology (medical)educationFactualAgedHepatologybusiness.industryCarcinomaSettore MED/09 - MEDICINA INTERNAHepatocellularmedicine.diseaseSurgeryProspective StudieYears of potential life lostLife expectancybusiness
researchProduct

Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology.

2013

The aims of severe perioperative bleeding management are three-fold. First, preoperative identification by anamesis and laboratory testing of those patients for whom the perioperative bleeding risk may be increased. Second, implementation of strategies for correcting preoperative anaemia and stabilisation of the macro- and microcirculations in order to optimise the patient's tolerance to bleeding. Third, targeted procoagulant interventions to reduce the amount of bleeding, morbidity, mortality and costs. The purpose of these guidelines is to provide an overview of current knowledge on the subject with an assessment of the quality of the evidence in order to allow anaesthetists throughout Eu…

Research Reportmedicine.medical_specialtyAdvisory CommitteesMedizinPsychological interventionMEDLINEBlood Loss Surgical610 Medicine & healthSeverity of Illness IndexMeta-Analysis as TopicAnesthesiologyhemic and lymphatic diseasesPreoperative CaremedicineHumans10220 Clinic for SurgeryDisease management (health)Grading (education)Societies MedicalRandomized Controlled Trials as Topicbusiness.industryDisease ManagementPerioperativeEvidence-based medicineGuidelinemedicine.diseaseSurgeryEuropeAnesthesiology and Pain MedicineSystematic reviewPractice Guidelines as TopicMedical emergency2703 Anesthesiology and Pain MedicinebusinessEuropean journal of anaesthesiology
researchProduct

Guideline-adherence and perspectives in the acute management of unstable angina - Initial results from the German chest pain unit registry.

2015

Abstract Background We investigated the current management of unstable angina pectoris (UAP) in certified chest pain units (CPUs) in Germany and focused on the European Society of Cardiology (ESC) guideline-adherence in the timing of invasive strategies or choice of conservative treatment options. More specifically, we analyzed differences in clinical outcome with respect to guideline-adherence. Method Prospective data from 1400 UAP patients were collected. Analyses of high-risk criteria with indication for invasive management and 3-month clinical outcome data were performed. Guideline-adherence was tested for a primarily conservative strategy as well as for percutaneous coronary interventi…

Risk profilingMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentMedizinCardiologyChest painPatient AdmissionPercutaneous Coronary InterventionRisk FactorsInternal medicineGermanymedicineHumansAcute managementAngina UnstableProspective StudiesRegistriesAgedGuideline adherenceUnstable anginabusiness.industryPercutaneous coronary interventionDisease ManagementGuidelineMiddle Agedmedicine.diseaseConventional PCIEmergency medicinePractice Guidelines as TopicPhysical therapyCardiologyGuideline Adherencemedicine.symptombusinessCardiology and Cardiovascular MedicineHospital UnitsJournal of cardiology
researchProduct

Risk-adapted management of pulmonary embolism

2017

The presence and severity of right ventricular (RV) dysfunction is a key determinant of prognosis in the acute phase of pulmonary embolism (PE). Risk-adapted treatment strategies continue to evolve, tailoring initial management to the clinical presentation and the functional status of the RV. Beyond pharmacological and, if necessary, mechanical circulatory support, systemic thrombolysis remains the mainstay of treatment for hemodynamically unstable patients; in contrast, it is not routinely recommended for intermediate-risk PE. Catheter-directed pharmacomechanical reperfusion treatment represents a promising option for minimizing bleeding risk; for reduced-dose intravenous thrombolysis, the…

Riskmedicine.medical_specialtyVentricular Dysfunction Rightmedicine.medical_treatmentHemorrhage030204 cardiovascular system & hematologyDabigatran03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEdoxabanInternal medicinemedicineHumansThrombolytic Therapy030212 general & internal medicineIntensive care medicineRivaroxabanbusiness.industryAnticoagulantsDisease ManagementHematologyThrombolysisPrognosismedicine.diseasePulmonary embolismchemistryCirculatory systemCardiologyApixabanPulmonary EmbolismbusinessMajor bleedingmedicine.drugThrombosis Research
researchProduct